Associated Papers
Restoration of mutant cytochrome P450 reductase activity by external flavin.
Nicolo C et al.
Molecular and Cellular Endocrinology, 2010
Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect.
Marohnic CC et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2010
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase.
Pandey AV et al.
Molecular Endocrinology (baltimore, Md.), 2007
Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
Flück CE et al.
Fundamental & Clinical Pharmacology, 2007
Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): a disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype.
Shackleton C et al.
American Journal of Medical Genetics. Part A, 2004
Select a paper to view details